14 results
IDSA Treatment of Necrotizing Infections of the Skin, Fascia, and Muscle
 • Mixed infections
 • Streptococcus
IDSA Treatment of ... of the Skin, Fascia ... #fasciitis #Skin ... #IDSA #Treatment ... #management #antibiotics
IDSA - Antimicrobial Therapy for Staphylococcal and Streptococcal Skin and Soft Tissue Infections
 • Impetigo (Staphylococcus
IDSA - Antimicrobial ... Streptococcal Skin ... Streptococcal #Antibiotics ... #management #treatment ... #idsa #cellulitis
IDSA Algorithm for the Management of Purulent skin and soft tissue infections (SSTIs). 
Mild infection: for
IDSA Algorithm for ... drainage plus oral antibiotics ... have failed oral antibiotic ... treatment or those ... #cellulitis #idsa
Clindamycin - Antibiotics Class Overview
-50 S inhibitor (PO and IV)
Spectrum: Excellent activity vs. Anaerobes and Gram
Clindamycin - Antibiotics ... Class Overview ... 50% of community-acquired ... Used for: skin/soft ... tissue infections
Monobactam - Aztreonam - Antibiotics Class Overview

Spectrum: only has activity vs. aerobic gram negatives, no gram
Class Overview ... for: hospital acquired ... , sepsis, skin and ... soft tissue infections ... #Review #Overview
Sulfonamides - Antibiotics Class Overview

BACTRIM/SEPTRA (TMP/SMX) - inhibit sequential steps in Folate synthesis --> bacteriostatic

Spectrum: Wide
Sulfonamides - Antibiotics ... Class Overview ... choice, both for treatment ... prophylaxis), Community-acquired ... MRSA Skin infections
Tetracyclines – Doxycycline, Tetracycline, Minocycline - Antibiotics Class Overview

- 30S Inhibitors (PO and IV)
Spectrum: Fairly broad
Minocycline - Antibiotics ... Class Overview ... Doxycycline - Skin ... suspect community-acquired ... #Review #Overview
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Tuberculosis Overview ... • Tuberculin skin ... Tuberculosis Treatment ... Initiating Treatment ... Diagnosis #Management #Treatment
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Tuberculosis Overview ... • Tuberculin skin ... Tuberculosis Treatment ... Initiating Treatment ... Diagnosis #Management #Treatment
IDSA - Approach to Treating a Patient With Diabetic Foot Osteomyelitis
When to consider a trial of
IDSA - Approach ... of nonsurgical treatment ... 48–72 h if on treatment ... not otherwise required ... nonoperative #management #IDSA